| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 5.2% | $1,132,575 | 501,739 | Anders Hove | 22 Dec 2025 | |||
| Oliveira Steven Michael | 4.09% | -20% | $69,324 | -$788,375 | 161,218 | -92% | Oliveira Steven Michael | 01 Oct 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,052 | $595 | -$5,287,828 | $2.26 | 2 |
| 2025 Q2 | 17,548,824 | $5,295,638 | +$4,106 | $0.302 | 50 |
| 2025 Q1 | 17,565,344 | $5,002,785 | -$111,730 | $0.2849 | 52 |
| 2024 Q4 | 17,923,414 | $10,513,884 | +$1,168,387 | $0.5867 | 54 |
| 2024 Q3 | 16,127,357 | $7,192,159 | -$16,853,612 | $0.446 | 56 |
| 2024 Q2 | 22,193,550 | $58,807,500 | +$1,275,233 | $2.65 | 65 |
| 2024 Q1 | 21,695,406 | $59,443,068 | -$117,105 | $2.74 | 73 |
| 2023 Q4 | 21,901,553 | $53,218,137 | -$1,833,437 | $2.43 | 64 |
| 2023 Q3 | 21,432,485 | $43,293,241 | -$1,354,746 | $2.02 | 70 |
| 2023 Q2 | 21,887,314 | $64,565,994 | -$5,409,932 | $2.95 | 76 |
| 2023 Q1 | 23,800,339 | $59,500,190 | +$2,342,756 | $2.5 | 81 |
| 2022 Q4 | 21,791,013 | $69,074,070 | +$2,745,077 | $3.17 | 92 |
| 2022 Q3 | 22,084,894 | $65,591,691 | +$171,025 | $2.97 | 94 |
| 2022 Q2 | 21,955,517 | $66,960,232 | -$100,026,928 | $3.05 | 89 |
| 2022 Q1 | 26,114,392 | $352,431,678 | +$183,845 | $13.5 | 99 |
| 2021 Q4 | 26,188,389 | $341,210,519 | +$17,550,511 | $13.03 | 97 |
| 2021 Q3 | 24,890,216 | $233,607,844 | +$136,180 | $9.38 | 91 |
| 2021 Q2 | 24,736,986 | $253,318,555 | -$61,367,283 | $10.24 | 86 |
| 2021 Q1 | 26,338,783 | $484,401,324 | +$83,845,702 | $18.4 | 68 |
| 2020 Q4 | 21,510,354 | $733,206,641 | +$29,318,645 | $34.25 | 69 |
| 2020 Q3 | 21,658,200 | $395,426,446 | +$395,426,446 | $18.46 | 54 |